See the DrugPatentWatch profile for Tenapanor
When does tenapanor’s product patent expire?
Tenapanor (marketed as IBSRELA) is covered by product and related patents, but the exact “product patent expiry” date depends on which specific patent(s) you mean (and the jurisdiction). Patent expiry is not one single date for all tenapanor-related rights; different patents expire at different times, and some may be extended or tied up in legal or regulatory proceedings.
Which patent should you check for tenapanor expiry (product vs. exclusivity)?
For tenapanor, “product patent expiry” is often used loosely to mean one of the following:
- The end of protection under a specific listed patent covering the drug substance or formulation.
- The end of exclusivity granted by regulators (which can be different from patent expiry).
- The end of protection for a particular commercial use or combination.
If you are trying to map a date from a label, payer policy, or a generic entry timeline, it usually helps to identify the exact patent number (and country) first, then read its stated expiration/term and any listed adjustments.
Does tenapanor face the same expiry rules in every country?
No. Patent term and any adjustments differ by country, and the governing filings can vary. A date in the US will not match a date in Europe or elsewhere, and exclusivity periods can differ from patent expiry even within the same country.
How can you find the exact tenapanor expiry date you need?
To get the precise expiry date for tenapanor’s product patent in the jurisdiction you care about, you typically need:
- The country (e.g., US, EP/UK, etc.).
- The specific patent number (or the patent family) you are tracking.
- Whether you want “patent expiry” or “regulatory exclusivity expiry.”
Once you have that, you can confirm the stated expiration date from the relevant official patent register or the regulatory listing that references those patents.
What happens if you’re looking at a “generic entry” date instead of pure patent expiry?
Generic (or follow-on) products may be delayed by:
- Patent thickets (multiple blocking patents with staggered expirations).
- Patent litigation or stays that can pause approval or launch.
- Regulatory exclusivity that extends beyond the first patent to expire.
So a “generic entry” date is often later than the earliest single patent expiry.
What I need to give you a specific expiry date
If you tell me:
1) the country/jurisdiction, and
2) whether you mean IBSRELA product patent expiry for the US/EP label specifically (and ideally the patent number),
I can help narrow to the correct expiry date(s) you’re looking for.
Sources (none provided in your prompt)
If you share a link or the patent numbers you’re using, I can interpret them and extract the relevant expiry date(s) accurately.